Tag: laboratory management services

November 28, 2016 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

In recent weeks, two different lab transactions were announced. One involved a hospital laboratory management contract and the other was a potential merger of two anatomic pathology lab companies. The first announcement came on October 31, when Lovelace Health System of Albuquerque, New Mexico, released news that it entered into an “inpatient and outpatient laboratory

View Article

Pathologists Benefit from Hospital Lab Consulting

CEO SUMMARY: Deteriorating finances at many rural hospitals and smaller community hospitals is a growing trend. It is also a new consulting opportunity for local pathologists because financially-strapped hospitals often give their labs inadequate working capital and lack the staff needed to comply fully with state and federal compliance requirements. In Shreveport, Louisiana, Delta Pathology

View Article

Halfpenny Technologies Buys Laboratory Management Services

TO BROADEN ITS CAPABILITIES in handling laboratory test data, Halfpenny Technologies, Inc., announced the acquisition of Laboratory Management Services (LMS) of Hauppauge, New York, earlier this month.

Halfpenny seems to be particularly interested in the informatics solutions developed by LMS to make it easier for clinical laboratories and pathology groups to report laboratory test data to

View Article

Pre-authorization Coming For Pricey Molecular Tests

CEO SUMMARY: In response to the steep ramp-up in the utilization of genetic and molecular testing, the nation’s largest health insurers are preparing to institute new guidelines for coverage and reimbursement. These will include pre-authorization by physicians, a more effective genetic test coding arrangement for claims submission by laboratories, and implementation of evidence-based medicine (EBM)

View Article

February 15, 2010 “Intelligence: Late Breaking Lab News”

In response to the sky-rocketing expenses associated with genetic and molecular testing, health insurers are planning ways to control both utilization and the prices at which these tests are reimbursed. For example, during the past year, Humana began using DNA Direct of San Francisco, California, to pre-authorize expensive genetic and molecular tests, while also advising

View Article